Live Breaking News & Updates on Anvisa

Stay informed with the latest breaking news from Anvisa on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Anvisa and stay connected to the pulse of your community

Clever Leaves Granted Brazilian GMP Certification for Cannabis Products by ANVISA

Multinational operator has been granted Brazilian GMP certification by ANVISA for the manufacturing of cannabis products Clever Leaves Holdings Inc. (NASDAQ:

Brazil , United-states , Colombia , America , Brazilian , Andres-fajardo , Brazilian-health-regulatory-agency , Clever-leaves-holdings-inc , Nasdaq , Strategic-communications , Leaves-holdings , Clever-leave-colombia

ClearPoint Neuro Announces ANVISA Approval of Neuro Navigation Portfolio in Brazil

ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today

United-states , Brazil , America , Brazilian , Megan-faulkenberry , Jacqueline-keller , Raquel-rodrigues , Exchange-commission , Nasdaq , Applications-of-the-company , Clearpoint-neuro-inc , Company-clearpoint-neuro-navigation-system

Kwality Pharmaceuticals received ANVISA approval for Cephalosporin Plant, Unit -II

Kwality Pharmaceuticals Ltd's finished dosage form manufacturing facility, after the approval of Oncology Injectable Unit from Anvisa, the Cephalosporin Unit situated at Himachal Pradesh has also been approved by ANVISA, Brazilian Health Regulatory Author

Himachal-pradesh , India , Brazil , Brazilian , Kwality-pharma , Kwality-pharmaceuticals , Brazilian-health-regulatory-authority , Kwality-pharmaceuticals-ltd , Brazil-national-health-surveillance-agency , Cephalosporin-plant , Pharmaceuticals-ltd , Oncology-injectable-unit

Alembic Pharmaceuticals Ltd passes ANVISA, Brazil GMP audit for its API-III Facility at Karakhadi

Alembic Pharmaceuticals Limited has successfully completed the Brazilian Health Regulatory Agency GMP audit at API-III Facility at Karakhadi without any observations for its 56 APIs.

Brazil , Alembic-pharmaceuticals-ltd , Brazilian-health-regulatory-agency , Alembic-pharmaceuticals , Pharmaceuticals-limited , Alembic-pharmaceuticals-limited , Alembicpharmaceuticals , Ine901l01018 , Anvisa , Gmpaudit , Api3facility

Kwality Pharmaceuticals receives approval from ANVISA for injectable unit

Kwality Pharmaceuticals Ltd has received approval from Brazil's National Health Surveillance Agency ANVISA for its Injectable formulations manufacturing unit at Amritsar along with Oncology Injectable Unit at Himachal Pradesh.

Himachal-pradesh , India , Amritsar , Punjab , Brazil , Brazilian , Kwality-pharmaceuticals , Brazil-national-health-surveillance-agency , Kwality-pharmaceuticals-ltd , Pharmaceuticals-limited , National-health-surveillance-agency

Covaxin Was Rushed Under Political Pressure, Need for Speed: STAT Report

One of Bharat Biotech’s directors has admitted to skipping ‘mandatory’ steps in the process of qualifying Covaxin.

Bhopal , Madhya-pradesh , India , Vellore , Tamil-nadu , New-delhi , Delhi , Brazil , Brazilian , Bharat , Krishna-mohan , Ed-silverman

Pfizer COVID vaccine approved for children as young as six months in Brazil

Rio De Janeiro: Brazilian national health regulator Anvisa has approved the COVID-19 vaccine produced by Pfizer and BioNTech for children aged between six months and four years, the government body...

Rio-de-janeiro , Estado-do-rio , Brazil , Brazilian , Pfizer , Anvisa , Pfizer-news , Covid-19 , Coronavirus , Coronavirus-vaccine , Biontech

Butantan Institute requests definitive registration of CoronaVac

BRASILIA. KAZINFORM - A year and a half after the approval of the emergency use of the CoronaVac vaccine against COVID-19, Brazil’s national drug regulator Anvisa received the application for its definitive registration. The request was sent by the Butantan Institute of São Paulo, Agencia Brasil reports.

Brasilia , Distrito-federal , Brazil , Agencia-brasil , Butantan-institute , Safety , Coronavac , Anvisa , Butantan , Institute , Requests , Definitive

Brazil sanitary agency Anvisa approves new drug for COVID-19 treatment

BRASILIA. KAZINFORM Brazil’s national drug authority Anvisa on Wednesday (Mar. 30) granted emergency authorization to COVID-19 treatment drug Paxlovid, a combination of nirmatrelvir and ritonavir. The product is manufactured by pharmaceutical company Wyeth.

Brasilia , Distrito-federal , Brazil , Meiruze-souza-freitas , Meiruze-freitas , Agencia-brasil , Helaine-capucho , Director-meiruze-souza-freitas , Drug-surveillance-manager-helaine-capucho , World-news , Coronavirus-vaccine

Brazil health regulator asks Bolsonaro to retract criticism over vaccines

The head of Brazil’s health regulator Anvisa has asked the country’s vaccine-sceptic President Jair Bolsonaro to retract statements he made criticising the agency for authorising the vaccination of children against Covid-19.

Brazil , Jair-bolsonaro , Anvisa , Antonio-barra-torres , Vaccines , Children , Pfizer , Covid-19 , Reaking-news , Eneral , Olitics